End-of-day quote
Other stock markets
|
||
- | - |
2023 | Kyung Nam Pharm Co.,Ltd. announced that it has received KRW 5 billion in funding | CI |
2023 | Kyung Nam Pharm Co.,Ltd. announced that it expects to receive KRW 5 billion in funding | CI |
Sales 2022 | 59B 43.31M 0 | Sales 2023 | 68.45B 50.24M 0 | Capitalization | 59.87B 43.94M 0 |
---|---|---|---|---|---|
Net income 2022 | -6.78B -4.98M - | Net income 2023 | -21B -15.41M - | EV / Sales 2022 | 1.19 x |
Net cash position 2022 | 12.28B 9.02M 0 | Net Debt 2023 | 16.32B 11.98M 0 | EV / Sales 2023 | 1.11 x |
P/E ratio 2022 |
-11.5
x | P/E ratio 2023 |
-2.84
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 70.94% |
Managers | Title | Age | Since |
---|---|---|---|
Seong-Won Oh
CEO | Chief Executive Officer | 46 | - |
Seung-Jae Lim
AUD | Comptroller/Controller/Auditor | 77 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Byung-Jin Kim
BRD | Director/Board Member | 46 | - |
Seong-Won Oh
CEO | Chief Executive Officer | 46 | - |
Hyeon-Bo Yoon
BRD | Director/Board Member | 53 | - |
1st Jan change | Capi. | |
---|---|---|
+19.98% | 43.48B | |
+20.67% | 22.65B | |
+14.56% | 14.73B | |
+44.72% | 12.04B | |
-8.37% | 7.08B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+11.90% | 5.47B | |
-2.27% | 4.81B |